Immune checkpoint inhibitors for advanced pancreatic cancer

Wei Yen Chan; Hao Wen Sim; Muhammad Abdi Haryono; Desmond Yip; Venessa Chin

doi:10.1002/14651858.CD014523

Immune checkpoint inhibitors for advanced pancreatic cancer

Wei Yen Chan
, Hao Wen Sim
, Muhammad Abdi Haryono
, Desmond Yip
, Venessa Chin^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of immune checkpoint inhibitors (ICIs), as monotherapy or in combination (with chemotherapy or targeted therapy), for people with advanced pancreatic cancer compared with chemotherapy, targeted therapy, or placebo.

Original language	English
Article number	CD014523
Journal	Cochrane Database of Systematic Reviews
Volume	2023
Issue number	2
DOIs	https://doi.org/10.1002/14651858.CD014523
Publication status	Published - 24 Feb 2023
Externally published	Yes

Access to Document

10.1002/14651858.CD014523

Chan_et_al-2023-Cochrane_Database_of_Systematic_ReviewsFinal published version, 148 KBLicence: Taverne

Cite this

@article{fe8db9c488be41778a3c0279da6be6ec,

title = "Immune checkpoint inhibitors for advanced pancreatic cancer",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of immune checkpoint inhibitors (ICIs), as monotherapy or in combination (with chemotherapy or targeted therapy), for people with advanced pancreatic cancer compared with chemotherapy, targeted therapy, or placebo.",

author = "Chan, \{Wei Yen\} and Sim, \{Hao Wen\} and \{Abdi Haryono\}, Muhammad and Desmond Yip and Venessa Chin",

note = "Publisher Copyright: Copyright {\textcopyright} 2023 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2023",

month = feb,

day = "24",

doi = "10.1002/14651858.CD014523",

language = "English",

volume = "2023",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley \& Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Immune checkpoint inhibitors for advanced pancreatic cancer

AU - Chan, Wei Yen

AU - Sim, Hao Wen

AU - Abdi Haryono, Muhammad

AU - Yip, Desmond

AU - Chin, Venessa

PY - 2023/2/24

Y1 - 2023/2/24

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of immune checkpoint inhibitors (ICIs), as monotherapy or in combination (with chemotherapy or targeted therapy), for people with advanced pancreatic cancer compared with chemotherapy, targeted therapy, or placebo.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of immune checkpoint inhibitors (ICIs), as monotherapy or in combination (with chemotherapy or targeted therapy), for people with advanced pancreatic cancer compared with chemotherapy, targeted therapy, or placebo.

UR - https://www.scopus.com/pages/publications/85150778620

U2 - 10.1002/14651858.CD014523

DO - 10.1002/14651858.CD014523

M3 - Article

AN - SCOPUS:85150778620

SN - 1465-1858

VL - 2023

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 2

M1 - CD014523

ER -

Immune checkpoint inhibitors for advanced pancreatic cancer

Abstract

Access to Document

Other files and links

Fingerprint

Cite this